AppBlogHilfeonvista bank
Werbung ausblenden
Aktie • Biotechnologie

BELLUS HEALTH

WKN
A2PQKK
Ticker
BLU
• BHN0
ISIN
CA07987C2040
Marktkapitalisierung
–
Dividendenrendite
–
KGV
–
Gewinn pro Aktie
–
Vola 30 Tage
8,46 %
theScreener Rating

Unternehmens­daten

Stammdaten zu BELLUS HEALTH

WKN
A2PQKK
ISIN
CA07987C2040
Home-Symbol
BLU
Symbol
BHN0
Branche
Biotechnologie
Sektor
Chemie / Pharma / Gesundheit
Unternehmen
Land

Marktdaten

Marktkapitalisierung
–
Anzahl Aktien
–
Streubesitz
–

Mitglieder & Anteilseigner

Anteilseigner

GSKRA Capital Management LPGoldman Sachs & Co. LLC (Private Banking)Pictet Asset Management SACommodore Capital LPOrbiMed Advisors Private EquityPerceptive Advisors LLCPower Corp of CanLaurion Capital Management LPRocabe Investments, Inc.Avidity Partners Management LPCitadel Advisors LLCBraidwell LPInvus Public Equities Advisors LLCDeerfield Management Co. LPPolar Capital LLPBoxer Capital LLCFirst Light Asset Management LLCMillennium Management LLCEventide Asset Management LLC
  • GSK (102,66 %)
  • RA Capital Management LP (9,99 %)
  • Goldman Sachs & Co. LLC (Private Banking) (5,83 %)
  • Pictet Asset Management SA (5,59 %)
  • Commodore Capital LP (5,20 %)
  • OrbiMed Advisors Private Equity (4,04 %)
  • Perceptive Advisors LLC (3,91 %)
  • Power Corp of Can (3,90 %)
  • Laurion Capital Management LP (3,82 %)
  • Rocabe Investments, Inc. (3,61 %)
  • Avidity Partners Management LP (3,60 %)
  • Citadel Advisors LLC (3,39 %)
  • Braidwell LP (3,26 %)
  • Invus Public Equities Advisors LLC (2,92 %)
  • Deerfield Management Co. LP (2,83 %)
  • Polar Capital LLP (2,81 %)
  • Boxer Capital LLC (2,53 %)
  • First Light Asset Management LLC (2,39 %)
  • Millennium Management LLC (2,24 %)
  • Eventide Asset Management LLC (1,75 %)

Kontakt

Werbung ausblenden